基于近期出血征象减少结肠憩室出血早期和晚期复发的治疗策略:一项大型多中心研究
本研究为日本49家医院的大型多中心回顾性分析,纳入5823例接受结肠镜检查的结肠憩室出血(CDB)患者,比较三种策略:找到近期出血征象(SRH,确诊CDB)并内镜治疗、找到SRH但保守治疗、未找到SRH(推测CDB)保守治疗。结果显示确诊CDB内镜治疗组早期和晚期复发率均显著低于推测CDB保守治疗组。
要点
- 确诊CDB内镜治疗组早期复发率19.6%,低于推测CDB保守治疗组的26.0%(P<.001)。
- 确诊CDB内镜治疗组晚期复发率33.7%,低于推测CDB保守治疗组的41.6%(P<.001)。
- 作者建议对疑似CDB应努力寻找并治疗SRH。
核心结论
- 确诊CDB内镜治疗在减少短期和长期复发方面最有效,优于不治疗确诊CDB或推测CDB。
- 作者建议医生对疑似CDB应努力寻找并治疗SRH。
研究设计与样本
- 回顾性分析日本49家医院的5823例接受结肠镜检查的CDB患者(CODE-BLUE J-Study)。
- 比较三种策略:找到SRH(确诊CDB)并内镜治疗、找到SRH(确诊CDB)保守治疗、未找到SRH(推测CDB)保守治疗。
- 采用倾向性评分匹配分析平衡组间基线特征。
主要发现
- 确诊CDB内镜治疗组早期复发率19.6%,推测CDB保守治疗组26.0%(P<.001)。
- 确诊CDB内镜治疗组晚期复发率33.7%,推测CDB保守治疗组41.6%(P<.001)。
- 确诊CDB患者中,内镜治疗组早期复发率17.4%,保守治疗组26.7%(P=.038,但多重检验校正后该显著性消失)。
- 确诊CDB患者中,内镜治疗组晚期复发率32.0%,保守治疗组36.1%(P=.426,无显著差异)。
- 在活动性出血、非活动性出血及右半结肠的SRH病例中,确诊CDB内镜治疗组早期和晚期复发率均显著低于保守治疗组,左半结肠则不然。
临床怎么用
- 作者认为对疑似CDB应努力寻找并治疗SRH。
局限性
- 原文报告为回顾性分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Treatment strategies for colonic diverticular bleeding (CDB) based on stigmata of recent hemorrhage (SRH) remain unstandardized, and no large studies have evaluated their effectiveness. We sought to identify the best strategy among combinations of SRH identification and endoscopic treatment strategies. METHODS: We retrospectively analyzed 5823 CDB patients who underwent colonoscopy at 49 hospitals throughout Japan (CODE-BLUE J-Study). Three strategies were compared: find SRH (definitive CDB) and treat endoscopically, find SRH (definitive CDB) and treat conservatively, and without finding SRH (presumptive CDB) treat conservatively. In conducting pairwise comparisons of outcomes in these groups, we used propensity score-matching analysis to balance baseline characteristics between the groups being compared. RESULTS: Both early and late recurrent bleeding rates were significantly lower in patients with definitive CDB treated endoscopically than in those with presumptive CDB treated conservatively (<30 days, 19.6% vs 26.0% [P < .001]; <365 days, 33.7% vs 41.6% [P < .001], respectively). In patients with definitive CDB, the early recurrent bleeding rate was significantly lower in those treated endoscopically than in those treated conservatively (17.4% vs 26.7% [P = .038] for a single test of hypothesis; however, correction for multiple testing of data removed this significance). The late recurrent bleeding rate was also lower, but not significantly, in those treated endoscopically (32.0% vs 36.1%, P = .426). Definitive CDB treated endoscopically showed significantly lower early and late recurrent bleeding rates than when treated conservatively in cases of SRH with active bleeding, nonactive bleeding, and in the right-sided colon but not left-sided colon. CONCLUSIONS: Treating definitive CDB endoscopically was most effective in reducing recurrent bleeding over the short and long term, compared with not treating definitive CDB or presumptive CDB. Physicians should endeavor to find and treat SRH for suspected CDB.
引用
- Gobinet-Suguro M, Nagata N, Kobayashi K, et al. Treatment strategies for reducing early and late recurrence of colonic diverticular bleeding based on stigmata of recent hemorrhage: a large multicenter study. Gastrointest Endosc. 2021. PMID: 34979112. doi:10.1016/j.gie.2021.12.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。